Despite the introduction of biologics for the treatment of rheumatological diseases in the 1990s, there are still unmet needs for proper modern day management of rheumatology at a global level. According to Samar Al Emadi et al, patients of the Emirate strongly prefer oral therapies for rheumatological diseases. This indicates that there is a considerable need for inclusion of novel oral targeted synthetic DMARD therapies in clinical practice within the region. Source: Emadi, S. A., Hammoudeh, M., Mounir, M., Mueller, R. B., Wells, A.
F., & Sarakbi, H. A. (2017) . An assessment of the current treatment landscape for rheumatology patients in Qatar: Recognising unmet needs and moving towards solutions . Journal of International Medical Research , 45 (2), 733–743.
